David Barr
Family Medicine · Lake Jackson, TXNPI 1972531200
Payments from drug & device makers
Across 253 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$762
- Sanofi-aventis U.S. LLC$460
- Amarin Pharma, Inc.$397
- Takeda Pharmaceuticals U.S.A., Inc.$267
- Lilly USA, LLC$257
- plus $1K from 23 others
What the payments were for
- Food & beverage$4,539100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 50 | $1,078 |
| AbbVie(2 entities) | 54 | $762 |
| Sanofi-aventis U.S. LLC | 27 | $460 |
| Amarin Pharma, Inc. | 20 | $397 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $267 |
| Lilly USA, LLC | 15 | $257 |
| Novo Nordisk | 14 | $241 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $197 |
| Boehringer Ingelheim | 11 | $175 |
| Lundbeck LLC | 6 | $120 |
| GSK | 5 | $100 |
| Johnson & Johnson | 5 | $83 |
| Eisai Inc. | 4 | $75 |
| Pfizer | 2 | $66 |
| Amgen | 2 | $46 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Abbott | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Shield Therapeutics Inc | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Adlon Therapeutics L.p. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Shire North American Group Inc | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Neos Therapeutics, LP | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Bristol Myers Squibb | 1 | $12 |
| Novartis | 1 | $11 |
| Corium, LLC | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,545 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 34 | $41,289 |
| FarxigaDapagliflozin Propanediol | 18 | $22,286 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $17,541 |
| Nebivolol Hcl | 13 | $1,534 |
| Rosuvastatin Calcium | 53 | $971 |
| Gabapentin | 48 | $749 |
| Atorvastatin Calcium | 82 | $703 |
| Montelukast Sodium | 80 | $690 |
| Valsartan | 37 | $645 |
| Duloxetine Hcl | 17 | $611 |
| Levothyroxine Sodium | 72 | $599 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 11 | $583 |
| Losartan Potassium | 37 | $438 |
| Metoprolol Succinate | 36 | $431 |
| Pantoprazole Sodium | 49 | $418 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $257 | $41,28934 claims |
| AstraZenecaFarxiga | $1,078 | $22,28618 claims |
| GSKTrelegy Ellipta | $100 | $17,54119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Lake Jackson
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.